Drug discovery

#Cell and gene therapy #Collaboration #Drug delivery #Drug discovery

Partnership hopes to improve large-scale exosome production

Bio-chromatography company Sartorius BIA Separations (BIA) and exosomes medicines company Exopharm have signed a Material Transfer Agreement and associated collaborative programme.  The partnership aims to combine Exopharm’s LEAP technology together with BIA’s CIM (Convective Interaction Media) monolith chromatography for improved large-scale therapeutic exosome production and commercialisation. … Read More

#Business & Investment #News

International Day of Action for Women's Health
#Diversity #Drug discovery #Life sciences #Women in Discovery #Women in STEM

Comment: Women in Discovery round-table welcomes men 

In the Summer 2022 issue of DDW, Jessica Woodgate and Molly Edwards from life sciences recruitment company SciPro shared with DDW their ambition to champion female leaders across drug discovery through the founding of the Women in Discovery round table. Since then, the women-only environment has… Read More

#Exclusive Content #Opinion

Scientists look at strand of DNA on screen
#AI #Artificial intelligence (AI) #Drug development #Drug discovery #Synthetic DNA

Researchers teach AI to tailor artificial DNA for drug development

Using artificial intelligence, researchers at Chalmers University of Technology, Sweden have succeeded in designing synthetic DNA that controls the cells’ protein production.  The technology can contribute to the development and production of vaccines and drugs for severe diseases much faster and at… Read More

#News

#Cancer research #Diabetes #Drug development #Drug discovery #FDA #Gene therapy #Haemophilia #MHRA #National Institute for Health and Care Excellence (NICE) #Neurodegenerative disorders

News update available on DDW Highlights podcast

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry news.  Gene therapies have made the headlines over the last week, with treatments… Read More

#News

Healthy cells
#Biomarkers #Drug discovery #RNA sequencing #Single-cell RNA sequencing #Webinar

Unperturbed, native state cells uncover biological targets

Extensive manipulation, mechanical force and labelling methods used to enrich cells activate transcriptional programs that mask molecular profiles truly significant to any underlying disease. The consequence is the identification of drug targets that are not relevant to the biological process under study.  Camila Egidio Based on Nakhoda and Olszanski,… Read More

Webinar date:
Brought to you by LevitasBio
#News

#Cancer research #Diabetes #Drug development #Drug discovery #FDA #Gene therapy #Haemophilia #MHRA #National Institute for Health and Care Excellence (NICE) #Neurodegenerative disorders

This week in drug discovery (21-25 November)

News round-up for 21-25 November by DDW Digital Content Editor Diana Spencer  Gene therapies have made the headlines over the last few days, with treatments for rare AADC deficiency, lung cancer and haemophilia B given the go ahead from regulators. This week has also seen the first… Read More

#News

Healthy cells
#Biomarkers #Drug discovery #RNA sequencing #Single-cell RNA sequencing

Broadening drug discovery: Use of unperturbed, native state cells to uncover true biological targets at single-cell level

Extensive manipulation, mechanical force, and labelling methods used to enrich cells activate transcriptional programs that mask molecular profiles truly significant to any underlying disease. The consequence is identification of drug targets that are not relevant to the biological process under study. Based on Nakhoda and Olszanski, 2022 (Addressing Recent Failures… Read More

Webinar date:
Brought to you by LevitasBio
#Webinars

#Biopharmaceuticals #Drug discovery #Drug targets #Drug technology #Pharmaceuticals #Quantum computing #R&D #Therapeutics

Podcast: Complex problems require complex solutions

This is the latest episode of the free DDW podcast, “Complex problems require complex solutions”. It covers two articles written for Volume 23, Issue 1 – Winter 2021/22 of DDW. They are called “How quantum computing can benefit drug discovery” and “Sitting down with Dr Michael Hayden from… Read More

#News

CST antibodies using the Cell DIVE multiplexed imaging solution
#Antibodies #Biomarkers #Cancer research #Collaboration #Drug discovery #Partnership

New antibody validation partnership hopes to “power scientific discovery” 

Leica Microsystems and Cell Signaling Technology (CST) have agreed a partnership to validate CST antibodies on the Cell DIVE multiplexed imaging solution.  As an open multiplexing system, Cell DIVE allows researchers to design custom antibody biomarker panels.  James O’Brien, Vice President Life Sciences at Leica… Read More

#Business & Investment #News

#Antibiotics #Antimicrobial resistance (AMR) #Cancer #Cancer research #Cell therapy #Covid-19 #Drug discovery #Oncology

Five key news stories available on DDW Highlights podcast

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  This week started with World Diabetes Day on 14 November and concluded… Read More

#News

#Antibiotics #Antimicrobial resistance (AMR) #Cancer #Cancer research #Cell therapy #Covid-19 #Drug discovery #Oncology

This week in drug discovery (14-18 November)

News round-up for 14-18 November by DDW Digital Content Editor Diana Spencer.  This week started with World Diabetes Day on 14 November and concluded with the start of World Antimicrobial Awareness Week, which aims to improve education and understanding of the growing issue of antimicrobial resistance. … Read More

#News

#Antibiotic resistance #Antimicrobial resistance (AMR) #Covid-19 #Drug discovery

AMR: why we need to advance the discovery of new antimicrobials

World Antimicrobial Awareness Week highlights the fact that antimicrobials have formed the bedrock of modern medicine, making surgeries, cancer care and treatments for life-threatening infections possible and improving human health in the process.  For years now, experts have laboured against the rise of antimicrobial resistance (AMR), urging… Read More

#Exclusive Content

#Drug discovery #Events #Genesis 2022 #Healthcare #Life sciences

Comment: Looking ahead to Genesis 2022 

The annual Genesis conference will take place on 7 December 2022 in London, and 5,6 and 8 December online, bringing key opinion leaders, investors and innovators from across the life sciences sector under one roof to exchange insights, debate trends and generate deals. DDW’s Megan Thomas will be in… Read More

#Exclusive Content

#Drug discovery #Molecular Biology #Synthetic biology

Global advances in synthetic biology

Lu Rahman selects some recent synthetic biology innovations and the potential they hold to benefit drug discovery.  The rapidly growing area of synthetic biology – including molecular biology, biotechnology, biophysics, and genetic engineering – is having a marked impact on the drug discovery landscape. Applying the principles of… Read More

#Exclusive Content

#Drug discovery #Genetic study #Health research programme #Healthcare #NHS #Predictive diagnostics #Public health

How Our Future Health will impact drug discovery 

Recently, DDW reported on how over three million people have been invited to join Our Future Health. Andrew Roddam, CEO of Our Future Health, shares the impact research programmes such as this will have on drug discovery.  Millions of people in the UK… Read More

#Exclusive Content #Opinion

#3D cell culture #Automated workflows #Cell Science #Drug discovery #Organ-on-a-chip #Organoids #Synthetic biology

What an innovation centre means for 3D biology

DDW Editor Reece Armstrong learns about Molecular Devices’ Organoid Innovation Centre (OIC) and how the company is aiming to advance research into 3D biology and organoids.  In April 2021, life sciences solutions provider Molecular Devices launched its Organoid Innovation Centre (OIC), an initiative designed to help scientists… Read More

#Exclusive Content